Cargando…
Complications of Anterior Cervical Fusion using a Low-dose Recombinant Human Bone Morphogenetic Protein-2
OBJECTIVE: There are several reports, which documented a high incidence of complications following the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in anterior cervical fusions (ACFs). The objective of this study is to share our experience with low-dose rhBMP-2 in anterior cervica...
Autores principales: | Kukreja, Sunil, Ahmed, Osama I, Haydel, Justin, Nanda, Anil, Sin, Anthony H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Spinal Neurosurgery Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513171/ https://www.ncbi.nlm.nih.gov/pubmed/26217385 http://dx.doi.org/10.14245/kjs.2015.12.2.68 |
Ejemplares similares
-
Trends, Costs, and Complications of Anterior Cervical Discectomy and Fusion With and Without Bone Morphogenetic Protein in the United States Medicare Population
por: Lord, Elizabeth L., et al.
Publicado: (2017) -
A Retrospective Analysis of Complications Associated With Bone Morphogenetic Protein 2 in Anterior Lumbar Interbody Fusion
por: Hindoyan, Kevork, et al.
Publicado: (2017) -
Anterior Cervical Discectomy and Fusion Using Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2: A Pilot Study
por: Son, Hee Jung, et al.
Publicado: (2022) -
Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?
por: Hoffmann, Martin Franz, et al.
Publicado: (2016) -
Anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2-adsorbed β-tricalcium phosphate granules: a preliminary report
por: Wang, Ze, et al.
Publicado: (2020)